CD79B and autoimmune disease: Although the bone marrow aging phenotypes reported here involve loss of B-cell populations expressing CD79B, the findings have important implications for conditions that involve aberrant activation of these pathways, especially considering that metabolic gatekeeper functions during B-cell development have been implicated in safeguarding against both autoimmune diseases and B-cell malignancies [60, 61].